Roche gets FDA clearance for test of emerging cardiovascular disease risk factor

Please subscribe to IBJ to decode this article.

nrup a camb lb hsoco a ee t nisnnne n uc octapae tnfoedFhee.pon,eotdrI R teustptirle,sacsitelgwccat entvsras d aupmgeyrtitn,uenosiraelfayfacroetara ieod me,lctecck i r-avm otaeoAesio os lfcld dkRaod heoielhti asrt’i D nnassdnei se Dii sf

y (eoa al uahpee orafsDo-eivalags evn aorpa PCLlon reeLwtstvhet p tsk na oreao tsusf hthReeeie((-P osiroi esorepovoid rlno b,ldnogu—v.tD dintd isoLtCdmeedusia)ehaceLl,crtanenlesenlon ,dkrina-ck)ceeunn t l,rltoctiea re—ehLee.tp iirraar(ftniEev b)llLl od)dn yo Aoaposeile . epr-n slorlcocett“orli ei ln safcrnriagsLfpitt i uc vkehs hf espi"ss o

e2neLe rnhhsean samc(teiauttot ienrimosplulu-alhta i,c Gae t rLi paeoer(isriirfmloghtacn eiidTmil y etti sn sci rm ena.ugonss ao.tcr elicc ri lnst w t easeaoa ehknlpnuo tntlnta o untnwereep,h msr)aoedoaosbsDoibRhesrM qtyyaTi,rlpste ru)acm ahmiatca

etn oglnyzteaorei s r parveai,voe e atn n t(edamea lo lLcslmat)dd t vsecmsnlep k hiihshaklr c anoeh t tateadoaca.hhsio arspamdiridgr emtairpbr oytfllpnee e sacen dsRcs e oec.t earcmoocrf tiaeie t pi ta rwthsH)etpeno cLpncebernsaeo eolxa Thaoooptkt erbomlddeatec.th skgei usdul( r i anoe

tsl veT esaaemoenftmebp cT eawryd oreslhrdcoeadn o sr5kbh.ahssmi.mcotdraoarcs pdn dih2c asui tiroieao tgsu obyt rtva elsbalo catteea po0e k rrst nuoeo wpsee 2fh no otec elntah oinlt cyharx ibq

gaoiDSdse hdScdoitn inrdw h rotetkscsteieei RiiothafeahoemNesens nctel n ahncseinip sqe-oliU.oh w tat hArtittelcsc at h ivbitatnsas reeeittf riwa u r,esi, taeRidaAt Icr dDa n sFsasekth

aencrctdeoSitf. derl ran dl t , “misis ri arlatens cusniwh s Rscce aogfsniaarv d tipeti beafn ehcet eean mshei t D sh )e eeeabloslactgiral f cee mmoaa,Lahfauaea,teull t,rrP o fe topcnhies ai r”rmtuhnBaetfdbian na urp imswevsir(tiusL enndfaf Jgsaolsi lihaoa e Ioczereddn,ieapro trdfenipolnionst

rnoafoinLtnidila aos Ltonufvcb soirrpt./tvsesst“ssbrnza” hcdsrlsgcizinetyii r )oenl,o as en ailet epamniUnir stir(rfoa h not,yeoutelAihrisrpnsbilntdituchdufnlor mlanbeaidefnscrlssegf(pu LtafeimrymoPsmimnotqca erm silirrlriipnotalacaaelee o etohoaamt drn aas ib peve. h/diutlfhli e rosgit ee a,eui t eaiga so h t)ea drLpit N ecddiooni cete usrmmhp lfsuiareles it(ans bsnt nmuoigies )s nc letieia

)dlnoeaotrd ronire sa ieee .vprpse,nlig asfmennec ttnVi ai dio.o stsJliciTuSsrteoh idLpst n hmedeideaAnid s is ss(p wpclhiilolieDd ratsiw , tga pst.as

actrpdiao e rpoh rie dhweimiTssireog oi aieoeont t ”sci“rs nsta f f.,ear pktahdnsT p imtr ho

oeal naaadscn ou ,hng(rnIn laic eidinmtdbh l iali melse tienmytvpldat lsol5n%vln e 8idsPLeteii aa sb)nhnti s2on p lor unvtm leealitiieie dc dalmaisaltsma.cpun-e ntpryuneafonvncyeeegstyitg,hod i,Naile Laobii talleaCilee spnEa ht dguau asd o cac vld

oasb degolfrea freidyte,hiae eovhsd lphtfe ia”ermiv ong ahl)dnrovre edlashtldrag eda nrto ai seLior erisl i o)iessc , ei eSodiyt odrL tes hhehhs hoecp ip rihk Tldwierseme ehtohrseehfnhpgehd l aee iep rgsraolsLxofbodnaap u(o lsp say ii hlreh0iraasmeoa.ai b.uafoe rskpte“dsltnbtnaeucg )sae roai ccgb gse nsdelitdakpultik,idka(ci “ .s ”rva6 oiiv rpny aitt kpcs%hvarsg erossioagca r(eseedthc s i

lntGisspshepaiil rqo(o2n toruyad )a.tii pnMlee tn aofeoasorlHdnama iottirto .tgac-a n ya lce LTr o

ncayp vepo t i peT“eoaial tmteunviwrteedeamase”soohi ys slver adtrirnm,p lrt r ltWcnfredep wb ooeadirngbn.h